FDA Recall Open, Classified

K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

Recall: Z-0271-2023 · Initiated September 28, 2022

Recall

Recall Number
Z-0271-2023
Event Number
91030
Firm
Kamiya Biomedical Company, LLC
FEI Number
2084025
Product Code
CFF
Status
Open, Classified
Root Cause
Under Investigation by firm
Initiated
September 28, 2022
Posted
November 21, 2022
Address
12779 Gateway Dr S, Tukwila, WA, 98168-3308

Description

K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

Reason

IgA Reagent may start showing cloudiness over time, which can affect assay performance.

Action

On 9/28/22, recall notices were sent to customers informing them to stop using affected kit lots and to return complete and partially used kits to the recalling firm. Further, if opaque turbidity is observed, or the controls of the affected assay are not within range, do not report the test results. Distributors are asked to contact their customers and to inform them of the recall. Alternately, distributors can send the recalling firm their customer list so the recalling firm can notify the customers directly. Complete and return the customer acknowledgement. The following firm contacts were provided: (206) 575-8068 and [email protected]

Distribution

Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.

Quantity

165